Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study (Q41612779)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 February 2007

Language	Label	Description	Also known as
English	Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study	scientific article published on 15 February 2007

Statements

scholarly article

1 reference

Europe PubMed Central

5 October 2017

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study (English)

1 reference

Europe PubMed Central

5 October 2017

cryopreservation

0 references

author name string

Griesinger G

1

1 reference

Europe PubMed Central

5 October 2017

von Otte S

2

1 reference

Europe PubMed Central

5 October 2017

Schroer A

3

1 reference

Europe PubMed Central

5 October 2017

Ludwig AK

4

1 reference

Europe PubMed Central

5 October 2017

Diedrich K

5

1 reference

Europe PubMed Central

5 October 2017

Al-Hasani S

6

1 reference

Europe PubMed Central

5 October 2017

Schultze-Mosgau A

7

1 reference

Europe PubMed Central

5 October 2017

language of work or name

0 references

publication date

15 February 2007

1 reference

Europe PubMed Central

5 October 2017

Human Reproduction

1 reference

Europe PubMed Central

5 October 2017

22

1 reference

Europe PubMed Central

5 October 2017

5

1 reference

Europe PubMed Central

5 October 2017

1348-1352

1 reference

Europe PubMed Central

5 October 2017

Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Reproductive biology and IVF: ovarian stimulation and endometrial receptivity

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Severe OHSS: yes, there is a strategy to prevent it!

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Highly efficient vitrification method for cryopreservation of human oocytes

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Experience with the elective transfer of two embryos under the conditions of the german embryo protection law: results of a retrospective data analysis of 2573 transfer cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEM006

21 January 2018

Identifiers

10.1093/HUMREP/DEM006

1 reference

Europe PubMed Central

5 October 2017

1 reference

Europe PubMed Central

5 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41612779&oldid=1925074855"